The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Medartis Holding AG's Revenue for the
six
months ended in Dec. 2025 was CHF146.2 Mil. Medartis Holding AG's average Accounts Receivable for the
six
months ended in Dec. 2025 was CHF48.2 Mil.
Hence, Medartis Holding AG's Receivables Turnover for the
six
months ended in Dec. 2025 was 3.03.
Medartis Holding AG (XSWX:MED) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Medartis Holding AG Receivables Turnover Related Terms
Medartis Holding AG Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:MED vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, Medartis Holding AG's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medartis Holding AG (XSWX:MED) has a Receivables Turnover of 3.03 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Medartis Holding AG and its competitors. According to the industry distribution chart, Medartis Holding AG ranks #366 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 45.1%.
Is Medartis Holding AG's Receivables Turnover too high?
Medartis Holding AG's current Receivables Turnover is 3.03. The Medical Devices & Instruments industry median Receivables Turnover is 5.53. Medartis Holding AG's value of 3.03 is 45.2% below this industry median. Based on the distribution chart, Medartis Holding AG ranks #366 out of 812 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medartis Holding AG has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #366 out of 812 companies for Receivables Turnover. This puts Medartis Holding AG in the upper half of its industry. The industry median Receivables Turnover is 5.53. Medartis Holding AG's value of 3.03 is 45.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.53, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current Receivables Turnover of 3.03 is 45.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Medartis Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current Receivables Turnover is 3.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF106.60, compared to a current price of CHF84.50 — trading 20.7% below its estimated fair value. The current Receivables Turnover is 3.03 and 45.2% below the Medical Devices & Instruments industry median of 5.53. Medartis Holding AG's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current Receivables Turnover is 3.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of CHF84.50 is trading 20.7% below its estimated GF Value™ of CHF106.60.
GuruFocus considers Medartis Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:MED:
Receivables Turnover: 3.03
GF Value™: CHF106.60 vs. price of CHF84.50 (20.7% below fair value)
Industry Position: 45.2% below the Medical Devices & Instruments median (#366 of 812)
No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
85GF Score
Get the complete analysis for XSWX:MED
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MED has been successfully added to your 
